Targeted protein degradation as a powerful research tool in basic biology and drug target discovery

被引:107
|
作者
Wu, Tao [1 ,2 ]
Yoon, Hojong [1 ,2 ]
Xiong, Yuan [1 ,2 ]
Dixon-Clarke, Sarah E. [1 ,2 ]
Nowak, Radoslaw P. [1 ,2 ]
Fischer, Eric S. [1 ,2 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
关键词
E3 UBIQUITIN LIGASE; STRUCTURAL BASIS; SELECTIVE DEGRADATION; RBM39; RECRUITMENT; COP9; SIGNALOSOME; LENALIDOMIDE; THALIDOMIDE; CANCER; INHIBITOR; MOLECULES;
D O I
10.1038/s41594-020-0438-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Controlled perturbation of protein activity is essential to study protein function in cells and living organisms. Small molecules that hijack the cellular protein ubiquitination machinery to selectively degrade proteins of interest, so-called degraders, have recently emerged as alternatives to selective chemical inhibitors, both as therapeutic modalities and as powerful research tools. These systems offer unprecedented temporal and spatial control over protein function. Here, we review recent developments in this field, with a particular focus on the use of degraders as research tools to interrogate complex biological problems. Small molecules that hijack the cellular protein ubiquitination machinery to selectively degrade proteins of interest have emerged as therapeutic modalities and powerful research tools. This Review summarizes recent developments in this field, with a focus on the use of degraders as research tools.
引用
收藏
页码:605 / 614
页数:10
相关论文
共 50 条
  • [31] Spatial Transcriptomics: A Powerful Tool in Disease Understanding and Drug Discovery
    Cao, Junxian
    Li, Caifeng
    Cui, Zhao
    Deng, Shiwen
    Lei, Tong
    Liu, Wei
    Yang, Hongjun
    Chen, Peng
    [J]. THERANOSTICS, 2024, 14 (07): : 2946 - 2968
  • [32] Tissue analysis - a powerful tool for drug discovery and development FOREWORD
    Ho, Stacy
    [J]. BIOANALYSIS, 2012, 4 (21) : 2545 - 2547
  • [33] Photoionization mass spectrometry - A powerful new tool for drug discovery
    Syage, JA
    Evans, MD
    [J]. SPECTROSCOPY, 2001, 16 (11) : 14 - +
  • [34] Morphogenics as a tool for target discovery and drug development
    Nicolaides, NC
    Ebel, W
    Kline, B
    Chao, QM
    Routhier, E
    Sass, PM
    Grasso, L
    [J]. TUMOR PROGRESSION AND THERAPEUTIC RESISTANCE, 2005, 1059 : 86 - 96
  • [35] Application of chemical biology in target identification and drug discovery
    Zhu, Yue
    Xiao, Ting
    Lei, Saifei
    Zhou, Fulai
    Wang, Ming-Wei
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (09) : 1642 - 1650
  • [36] Synthetic Biology Speeds Up Drug Target Discovery
    Xie, Yixuan
    Yang, Yanfang
    He, Yu
    Wang, Xixi
    Zhang, Peng
    Li, Haocheng
    Liang, Shufang
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [37] Application of chemical biology in target identification and drug discovery
    Yue Zhu
    Ting Xiao
    Saifei Lei
    Fulai Zhou
    Ming-Wei Wang
    [J]. Archives of Pharmacal Research, 2015, 38 : 1642 - 1650
  • [38] Systems biology visualization tools for drug target discovery
    Huan, Tianxiao
    Wu, Xiaogang
    Chen, Jake Y.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (05) : 425 - 439
  • [39] Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation
    Gross, Patrick H.
    Sheets, Katie J.
    Warren, Noel A.
    Ghosh, Saptarshi
    Varghese, Rebekah E.
    Wass, Katherine E.
    Kadimisetty, Karteek
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 628 : 68 - 75
  • [40] The Use of Structural Biology in Janus Kinase Targeted Drug Discovery
    Alicea-Velazquez, Nilda L.
    Boggon, Titus J.
    [J]. CURRENT DRUG TARGETS, 2011, 12 (04) : 546 - 555